229 related articles for article (PubMed ID: 21422323)
1. Rituximab for patients with refractory mucous membrane pemphigoid.
Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
[TBL] [Abstract][Full Text] [Related]
2. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575
[No Abstract] [Full Text] [Related]
3. Refractory mucous membrane pemphigoid which developed after allogeneic stem cell transplantation and was successfully treated with rituximab.
Nishimura R; Fujimoto N; Kito K; Uchiyama K; Koga H; Hodohara K; Hashimoto T; Fujiyama Y; Tanaka T
Eur J Dermatol; 2013; 23(4):562-4. PubMed ID: 24001878
[No Abstract] [Full Text] [Related]
4. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
Li Y; Foshee JB; Sontheimer RD
J Am Acad Dermatol; 2011 Apr; 64(4):773-8. PubMed ID: 20494477
[TBL] [Abstract][Full Text] [Related]
5. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
[TBL] [Abstract][Full Text] [Related]
6. Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.
Shetty S; Ahmed AR
J Am Acad Dermatol; 2013 Mar; 68(3):499-506. PubMed ID: 23200198
[TBL] [Abstract][Full Text] [Related]
7. Taking responsibility for complex medical dermatology patient management.
Zone JJ
Arch Dermatol; 2011 Jul; 147(7):850. PubMed ID: 21768485
[No Abstract] [Full Text] [Related]
8. Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid.
Munyangango EM; Le Roux-Villet C; Doan S; Pascal F; Soued I; Alexandre M; Heller M; Lièvre N; Aucouturier F; Caux F; Laroche L; Prost-Squarcioni C
Br J Dermatol; 2013 Feb; 168(2):381-90. PubMed ID: 22963186
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in mucous membrane pemphigoid.
Daniel E; Thorne JE
Curr Opin Ophthalmol; 2008 Jul; 19(4):292-7. PubMed ID: 18545009
[TBL] [Abstract][Full Text] [Related]
10. Current medical treatment of ocular mucous membrane pemphigoid.
Sobolewska B; Deuter C; Zierhut M
Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
[TBL] [Abstract][Full Text] [Related]
11. [Cicatricial pemphigoid, mucous membrane pemphigoid].
Doffoel-Hantz V; Robert PY; Bédane C
Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
[TBL] [Abstract][Full Text] [Related]
12. Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.
Taverna JA; Lerner A; Bhawan J; Demierre MF
J Drugs Dermatol; 2007 Jul; 6(7):731-2. PubMed ID: 17763598
[TBL] [Abstract][Full Text] [Related]
13. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for severe mucous membrane pemphigoid: safe enough to be drug of first choice?
Hertl M; Bernard P; Borradori L
Arch Dermatol; 2011 Jul; 147(7):855-6. PubMed ID: 21768487
[No Abstract] [Full Text] [Related]
15. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
[No Abstract] [Full Text] [Related]
16. Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab.
Schumann T; Schmidt E; Booken N; Goerdt S; Goebeler M
Acta Derm Venereol; 2009; 89(1):101-2. PubMed ID: 19197558
[No Abstract] [Full Text] [Related]
17. Mucous membrane pemphigoid with antibodies against β3 subunit of laminin-332: first report from India.
Kanwar AJ; Vinay K; Koga H; Hashimoto T
Indian J Dermatol Venereol Leprol; 2012; 78(4):475-9. PubMed ID: 22772619
[TBL] [Abstract][Full Text] [Related]
18. Treatment of mucous membrane pemphigoid with rituximab.
Heelan K; Walsh S; Shear NH
J Am Acad Dermatol; 2013 Aug; 69(2):310-1. PubMed ID: 23866864
[No Abstract] [Full Text] [Related]
19. Reply to "Treatment of mucous membrane pemphigoid with rituximab".
Ahmed AR; Shetty S
J Am Acad Dermatol; 2013 Aug; 69(2):311-2. PubMed ID: 23866865
[No Abstract] [Full Text] [Related]
20. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
